Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (1): 49-54.doi: 10.6040/j.issn.1671-7554.0.2020.1112
Previous Articles Next Articles
YOU Xueting1, TIAN Xingsong1,2
CLC Number:
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] Leong SP, Shen ZZ, Liu TJ, et al. Is breast cancer the same disease in Asian and Western countries? [J]. World J Surg, 2010, 34(10): 2308-2324. [3] Fan L, Zheng Y, Yu KD, et al. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China [J]. Breast Cancer Res Treat, 2009, 117(2): 409-416. [4] Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China [J]. Lancet Oncol, 2014, 15(7): e279-e289. [5] Fan L, Goss PE, Strasser-Weippl K. Current status and future projections of breast cancer in asia [J]. Breast Care(Basel), 2015, 10(6): 372-378. [6] Kim Z, Min SY, Yoon CS, et al. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database [J]. J Breast Cancer, 2015, 18(2): 103-111. [7] Li J, Zhang BN, Fan JH, et al. A nation-wide multicenter 10-year(1999-2008)retrospective clinical epidemiological study of female breast cancer in China [J]. BMC Cancer, 2011, 11: 364. [8] Shi J, Liang D, Jin J, et al. Female breast cancer burden was increasing during the 40 years in Hebei Province, China: a population-based study [J]. Arch Gynecol Obstet, 2016, 294(5): 1063-1071. [9] 李全华, 马万里, 姚开颜, 等. 浙江省嘉善县1988~2012年女性乳腺癌发病趋势分析[J].中国肿瘤, 2015, 24(1): 22-26. LI Quanhua, MA Wanli, YAO Kaiyan, et al. An Analysis of Incidence Trend of Female Breast Cancer in Jiashan County, Zhejiang Province,1988~2012 [J]. China Cancer, 2015, 24(1): 22-26. [10] 王铁霖. 中国西部9868例乳腺癌发病年龄及激素受体状态分析[D]. 重庆: 重庆医科大学, 2018. [11] 徐英, 雷林, 刘峥, 等. 2001~2015年深圳市女性乳腺癌发病年龄特征分析[J]. 现代预防医学, 2019, 46(13): 2375-2378. XU Ying, LEI Lin, LIU Zheng, et al. Age characteristics of female breast cancer, Shenzhen,2001-2015 [J]. Modern Preventive Medicine, 2019, 46(13): 2375-2378. [12] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(1): 7-34. [13] Liu N, Johnson KJ, Ma CX. Male breast cancer: an updated surveillance, epidemiology, and end results data analysis [J]. Clin Breast Cancer, 2018, 18(5): e997-e1002. [14] Ishii T, Nakano E, Watanabe T, et al. Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan [J]. Cancer Med, 2020, 9(16): 6069-6075. [15] 赵敏, 尹菊芬, 龙飞, 等. 5917例乳腺癌患者疾病构成特征分析[J].中国病案, 2018, 19(3): 63-66. ZHAO Min, YIN Jufen, LONG Fei, et al. Analysis on the disease composition characteristics of 5917 cases of breast cancer patients [J]. Chinese Medical Record, 2018, 19(3): 63-66. [16] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132. [17] 李祥, 郑红梅, 何建平, 等. 2012年湖北省乳腺癌发病与死亡情况分析[J]. 肿瘤防治研究, 2018, 45(2): 96-100. LI Xiang, ZHENG Hongmei, HE Jianping, et al. Breast cancer incidence and mortality in hubei province, 2012 [J]. Cancer Research on Prevention and Treatment, 2018, 45(2): 96-100. [18] Kollias J, Pinder SE, Denley HE, et al. Phenotypic similarities in bilateral breast cancer [J]. Breast Cancer Res Treat, 2004, 85(3): 255-261. [19] Hartman M, Czene K, Reilly M, et al. Genetic implications of bilateral breast cancer: a population based cohort study [J]. Lancet Oncol, 2005, 6(6): 377-382. [20] Kheirelseid EA, Jumustafa H, Miller N, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics [J]. Breast Cancer Res Treat, 2011, 126(1): 131-140. [21] Carmichael AR, Bendall S, Lockerbie L, et al. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours [J]. Eur J Surg Oncol, 2002, 28(4): 388-391. [22] Schmid SM, Pfefferkorn C, Myrick ME, et al. Prognosis of early-stage synchronous bilateral invasive breast cancer [J]. Eur J Surg Oncol, 2011, 37(7): 623-628. [23] Tot T. The role of large-format histopathology in assessing subgross morphological prognostic parameters: a single institution report of 1000 consecutive breast cancer cases [J]. Int J Breast Cancer, 2012, 2012: 395415. doi: 10.1155/2012/395415. [24] Lynch SP, Lei X, Chavez-MacGregor M, et al. Multifocality and multicentricity in breast cancer and survival outcomes [J]. Ann Oncol, 2012, 23(12): 3063-3069. [25] Bendifallah S, Werkoff G, Borie-Moutafoff C, et al. Multiple synchronous(multifocal and multicentric)breast cancer: clinical implications [J]. Surg Oncol, 2010, 19(4): e115-e123. [26] Salgado R, Aftimos P, Sotiriou C, et al. Evolving paradigms in multifocal breast cancer [J]. Semin Cancer Biol, 2015, 31: 111-118. doi: 10.1016/j.semcancer.2014.07.002. [27] Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer [J]. J Clin Oncol, 2008, 26(19): 3248-3258. [28] Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy [J]. Int J Radiat Oncol Biol Phys, 2001, 50(3): 735-742. |
[1] | Yun LIN,Yanqiu XIE. Fertility protection and preservation in breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 42-46. |
[2] | HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43. |
[3] | Qifeng YANG,Ning ZHANG. Sentinel lymph node biopsy of breast cancer in the era of precision medicine [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 1-5. |
[4] | ZHAO Tingting, QI Yana, ZHANG Ying, YUAN Bing, HAN Mingyong. Mouse breast cancer induces changes of the microenvironment in pre-metastatic lung tissue [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 24-29. |
[5] | FENG Haigang, LIU Guowen, CAO Hong. Effects and mechanism of interfering MAD2L1 gene expression on the apoptosis of breast cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 9-16. |
[6] | Zhuxiu CHU,Wenjing ZHAO,Xiaoyan LI,Xiaoli KONG,Tingting MA,Liyu JIANG,Qifeng YANG. Significance of neoadjuvant chemotherapy and molecular marker changes in 218 women with breast cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 130-139. |
[7] | WANG Zhe, LIU Yujie, MAO Qian, GUAN Peixia, BAO Qihan, LI Chengsheng, QIAO Xiaowei, PAN Qingzhong, WANG Suzhen. Evaluation of the efficacy of different regimens for early triple negative breast cancer based on the inverse probability of treatment weighting method [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 113-118. |
[8] | LI Wanwan, ZHOU Wenkai, DONG Shuqing, HE Shiqing, LIU Zhao, ZHANG Jiaxin, LIU Bin. Construct of a risk assessment model of breast cancer immune-related lncRNAs based on the database information [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 74-84. |
[9] | KONG Xue, LI Juan, DUAN Weili, SHI Shuang, LI Peilong, DU Lutao, MAO Haiting, WANG Chuanxin. Effects of lncRNA AC012073.1 on the migration and invasion of human breast cancer cells and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 70-78. |
[10] | GUO Tian, FU Yilin, GAO Ling, SONG Yongfeng, FU Guobin, GENG Chong, WANG Weibo. Correlation between thyroid hormonal levels and clinical characteristics of 142 women with breast cancer [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 53-59. |
[11] | CAO Aihua, DUAN Chunhong, QIU Bingping, LU Ling, LI Keliang, LIU Xuegong, ZHOU Zhiyuan, SUN Jianhua, JU Xiuli. Epidemiological and clinical characteristics of children infected with SARS-CoV-2 in Shandong Province [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 34-40. |
[12] | YANG Xuemei, LI Juan, WANG Yifan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Significance of a three-lncRNAs signature on the prediction of survival for HER2 positive breast cancer patients [J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 69-76. |
[13] | WANG Huasheng, OU Renjie, WANG Mo, BAI Longzhen,LI Yingjie, SUN Chao, WANG Yongmei. Clinical features of 9 cases of cryptogenic organizing pneumonia and literature review [J]. Journal of Shandong University (Health Sciences), 2020, 58(1): 81-86. |
[14] | LUAN Na, LIU Liyuan, WANG Fei, ZHOU Fei, XIANG Yujuan, HUANG Shuya, ZHENG Chao, YU Lixiang, YU Zhigang. A study of sleep quality of patients with breast cancer and influencing factors [J]. Journal of Shandong University (Health Sciences), 2019, 57(4): 59-64. |
[15] | LI Fan, SHAO Jianhua, ZHAO Hongyu, DOU Chunhui, LÜ Yahui, LI Daqi. Clinical features and prognosis of adult secondary hemophagocytic syndrome: an analysis of 32 cases [J]. Journal of Shandong University (Health Sciences), 2019, 57(12): 62-67. |
|